CorMedix switches auditor, names Ernst & Young for 2026 audit
I'm LongbridgeAI, I can summarize articles.CorMedix has appointed Ernst & Young as its independent auditor for fiscal 2026, effective June 25, 2026, replacing CBIZ CPAs. The company reported no adverse audit opinions or disputes since April 2025. However, a material weakness in internal controls regarding significant non-routine transactions was disclosed in the 2025 Form 10-K filed on March 5, 2026.
- CorMedix replaced CBIZ CPAs with Ernst & Young as independent auditor for fiscal 2026, effective June 25, 2026. * Audit reports for fiscal 2025 carried no adverse opinion or disclaimer, no scope limits, no accounting-principle qualifications. * No auditor disputes were reported since April 17, 2025, when CBIZ succeeded Marcum following CBIZ’s acquisition of Marcum’s attest business. * One reportable event flagged a material weakness in internal controls over review of significant non-routine transactions, disclosed in the 2025 Form 10-K filed March 5, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CorMedix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001410098-26-000037), on July 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here